sorafenib has been researched along with thioacetamide in 4 studies
| Studies (sorafenib) | Trials (sorafenib) | Recent Studies (post-2010) (sorafenib) | Studies (thioacetamide) | Trials (thioacetamide) | Recent Studies (post-2010) (thioacetamide) |
|---|---|---|---|---|---|
| 6,520 | 730 | 5,251 | 1,705 | 4 | 655 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 3 (75.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chou, H; Fiel, MI; Friedman, SL; Hong, F | 1 |
| Bonney, G; Chow, P; Dan, YY; Huang, DQ; Jumat, H; Kow, A; Lee, GH; Lim, SG; Lim, YT; Muthiah, MD; Pang, YH; Shridhar, I; Soon, G; Tan, WX; Wee, A; Zhou, L | 1 |
| Abdel-Hamed, AR; Abo-Elmatty, DM; Abulsoud, AI; Al-Noshokaty, TM; Mesbah, NM | 1 |
| Abo El-Magd, NF; El Gayar, AM; Yousef, EH | 1 |
4 other study(ies) available for sorafenib and thioacetamide
| Article | Year |
|---|---|
Antifibrotic activity of sorafenib in experimental hepatic fibrosis: refinement of inhibitory targets, dosing, and window of efficacy in vivo.
Topics: Animals; Cells, Cultured; Dose-Response Relationship, Drug; Gene Expression Regulation; Hepatic Stellate Cells; Humans; Liver Cirrhosis; Male; Niacinamide; Phenylurea Compounds; Rats; Rats, Sprague-Dawley; RNA; Sorafenib; Thioacetamide | 2013 |
Predicting HCC Response to Multikinase Inhibitors With In Vivo Cirrhotic Mouse Model for Personalized Therapy.
Topics: Adult; Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Carcinoma, Hepatocellular; Cell Proliferation; Disease Models, Animal; Female; Humans; Liver Cirrhosis; Liver Neoplasms; Male; Mice; Mice, Inbred NOD; Mice, SCID; Middle Aged; Neovascularization, Pathologic; Phenylurea Compounds; Precision Medicine; Prognosis; Protein Kinase Inhibitors; Quinolines; Sorafenib; Thioacetamide; Tumor Cells, Cultured; Tumor Microenvironment; Xenograft Model Antitumor Assays | 2021 |
Selenium nanoparticles overcomes sorafenib resistance in thioacetamide induced hepatocellular carcinoma in rats by modulation of mTOR, NF-κB pathways and LncRNA-AF085935/GPC3 axis.
Topics: Animals; Antineoplastic Agents; bcl-2-Associated X Protein; Carcinoma, Hepatocellular; Caspase 3; Cell Line, Tumor; Glypicans; Liver Neoplasms; Mammals; Nanoparticles; NF-kappa B; Proto-Oncogene Proteins c-akt; Rats; RNA, Long Noncoding; Selenium; Sorafenib; Thioacetamide; TOR Serine-Threonine Kinases | 2022 |
Carvacrol enhances anti-tumor activity and mitigates cardiotoxicity of sorafenib in thioacetamide-induced hepatocellular carcinoma model through inhibiting TRPM7.
Topics: Animals; Antineoplastic Agents; Carcinoma, Hepatocellular; Cardiotoxicity; Cell Line, Tumor; Cell Proliferation; Liver Neoplasms; Rats; Sorafenib; Thioacetamide; TRPM Cation Channels | 2023 |